Patents
The invention provides 3-arylethynyl substituted quinazolinone compounds of formula (A) as potential anticancer agents against sixty human cancer cell lines. R1dbd.H, OH, OCH3; R2dbd.H, OH, CH3, OCH3, NO2; R3.dbd.H, OH, OCH3, F, Cl; R2+R3=--OCH2O--; R4.dbd.H, OH, CH3, OCH3; R5.dbd.H, OH, CH3, OCH3; R6.dbd.H, OCH3.